Plasma insulin and blood glucose during long-term treatment with diazoxide for infant hypoglycemia.
D000138:Acidosis / Q000139:chemically induced; D001786:Blood Glucose / Q000378:metabolism*; D002675:Child, Preschool; D003981:Diazoxide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005947:Glucose / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced; D007003:Hypoglycemia / Q000150:complications / Q000151:congenital / Q000188:drug therapy*; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin / Q000097:blood*; D008607:Intellectual Disability / Q000209:etiology; D007930:Leucine; D013268:Stimulation, Chemical; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D007930:Leucine; D005947:Glucose; D003981:Diazoxide